Does Dr. ROBERT BACIGALUPI have financial conflicts of interest?

Dr. ROBERT BACIGALUPI (M.D.) has received a total of $75,810 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $75,810 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ROBERT BACIGALUPI?

According to CMS Open Payments data, Dr. ROBERT BACIGALUPI received funding from GALDERMA LABORATORIES, L.P ($74,415), ABBVIE ($407), and NOVARTIS PHARMACEUTICALS CORPORATION ($363).

Does Dr. ROBERT BACIGALUPI receive research grants or speaking fees?

Dr. ROBERT BACIGALUPI has received $75,810 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ROBERT BACIGALUPI

M.D.Real-Time Hydrated

Specialty: Dermatology, Procedural Dermatology

Practice Location: GARDEN CITY, NY 11530

NPI Number: 1740505668

LIFETIME INDUSTRY VALUE

$75,810

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BACIGALUPI is a verified Dermatology, Procedural Dermatology practitioner based in GARDEN CITY, NY.

Between 2021 and 2025, Dr. BACIGALUPI had an overall industry promotional and research financial footprint of $75,810 as recorded in the federal CMS Open Payments database.

$75,810 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BACIGALUPI's primary funding source is GALDERMA LABORATORIES, L.P, which accounts for $74,415 (representing 98.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GALDERMA LABORATORIES, L.P

Rank 1

$74,415

98.2%

ABBVIE

Rank 2

$407

0.5%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 3

$363

0.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.